Key facts
- Notable investors include GSR Ventures China.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Dr.Leo
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr.Leo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr.Leo
Manufacturer of medical skincare products intended to support skin care routines using science-based formulations. The company develops dermatologist-reviewed products focused on acne treatment, brightening, anti-aging, and skin barrier repair, through in-house research and development involving medical professionals, enabling consumers across various skin types to use clinically informed skincare products for clear, healthy-looking skin.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Kuala Lumpur, Malaysia
- Founded
- 2022
- Website
- drleo.com/
- Ownership
- Privately Held (backing)
Dr.Leo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr.Leo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr.Leo in its N-PORT filings yet. We sweep new filings monthly.